Hide Board Information

Show Board Information

YY Inc. YY

Board Mod: allinall

Asst Mods:

Last Post: 01/03/2024 8:15:48 AM

Board Marks: 1

Posts Today: 0

Board Views Today: 6

YY Inc. (NASDAQ: YY) Stock Message Board

1. YY Company Profile

    

2. YY Time & Sales

    

3. YY Recent News

    

4. YY Filings

    

5. YY Financials

    

6. YY Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

6	YY 75.98 YY Inc $YY added to my watch list. Right	clayton	11/17/2014 12:19:37 PM
5	Volume Alert - YY 75.05 YY Inc $YY Hit a high	leahanne	11/14/2014 1:56:30 PM
4	YY up +4.12% percent Today $YY High is at 74.87	Lucky Jimmy	11/14/2014 10:38:57 AM
3	Volume Alert - YY 79.01 YY Inc $YY Hit a high	leahanne	11/12/2014 12:46:10 PM
2	YY up +2.16% percent Today $YY High is at 83.30	Lucky Jimmy	11/10/2014 1:09:12 PM
1	YY Stock Chart 65.03 Monday, February 10, 2014	chartguy89	02/10/2014 8:52:50 AM

Newer

Recent Articles

• CLINUVEL Completes Enrollment in Groundbreaking Vitiligo Study
• Understanding Recent Bitcoin Volatility Trends with Bybit
• Revolutionizing Maritime AI through Innovative Partnerships
• Empowering Future Farmers: Microsoft and FFA's Innovative Program
• Grant Industries Partners with Labbit for Enhanced Digital Solutions
• NetDragon Leads the Charge in Digital Innovation and Learning
• Empowering Climate Finance: Launch of GCBC Accelerator Initiative
• GCBC Accelerator Launch: Advancing Climate Finance Solutions
• ISC Reports Robust Q1 Performance with Significant Growth
• ISC Announces Quarterly Dividend, Strengthens Financial Position
• Community Efforts Shine During ALS Awareness Month Advocacy
• Caplight's Innovative Patent Sets New Standards in Pricing Transparency
• Revolutionizing Animation Production: CreateAI's Insights Revealed
• Revolutionizing Electric Vehicles: HIGHLY's Thermal Solutions
• LONGi and ENGIE Team Up to Elevate Solar Energy Standards
• Liberty Energy Solutions to Acquire PEC Ltd. for US$160 Million
• TIER IV Leads the Charge in Autonomous Driving Standards
• An Unforgettable Evening with Shatner and Tyson: Join Us!
• Karat Packaging Board Approves Regular Dividend for Shareholders
• Civitas Resources Inc. Faces Class Action Lawsuit for Misleading
• Exploring the Lucrative HALS Market Growth Projections
• Empowering Future Leaders: Dr. Austin Harris's Grant
• Empowering Future Sports Professionals with a New Scholarship
• Innovative Research on Nucleic Acid Technologies by Ajinomoto
• Innovative Advances in Cancer Therapy by CStone Pharmaceuticals
• Innovent Launches First Patient Dosing for New DME Treatment
• Innovative Research Boosts Aptamer Technology by Ajinomoto
• Fidelity D & D Bancorp Declares Q2 2025 Dividend Payment
• Teamsters at Seattle Airport Vote to Strike Against Swissport
• Empowering Tomorrow's Real Estate Leaders Through Education
• California's Bill AB 446 Aims to Protect Consumers from Pricing Abuse
• Veltex Corporation Expands Board with New Strategic Leaders
• Bellroy Unveils Innovative Luggage Solutions for Travel Enthusiasts
• Propelis Emerges as a Major Brand Agency Powerhouse
• MPLX and Enbridge Join Forces on Matterhorn Express Pipeline
• Edgewood Monuments Expands Custom Memorial Services Across USA
• Allied Properties' Latest Unitholder Meeting Unveils Key Decisions
• Insightful Analysis of Overspending in Police Overtime
• Investigation Launched for Investors of Take-Two Software
• Adcentrx Therapeutics Accelerates Development of ADRX-0706
• Montage Gold Expands Influence in Côte d’Ivoire Gold Sector
• Osisko Development's Q1 2025 Results: Growth and Progress Insights
• Ardelyx, Inc. Faces Investigation After Financial Shortfall
• Veterans' Impact Highlighted at Washington Hearing with Independence Fund
• Integra LifeSciences Faces Investigation Over Financial Discrepancies
• Investigation of PTC Therapeutics: Examining Investor Claims
• Strong Performance Declared by IRSA for Third Quarter 2025
• Passenger Traffic Growth Soars for Grupo Aeroportuario del Pacífico
• Western Forest Products Reports Strong Q1 2025 Growth
• Formosa Pharmaceuticals Expands Licensing for Innovative Eye Treatment